---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-067504"
form_type: "8-K"
ticker: "VRDN"
cik: "0001590750"
company_name: "Viridian Therapeutics, Inc.\\DE"
filed_at: "2023-03-10T23:59:59+00:00"
generated_at: "2026-06-18T05:29:30.137446+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Viridian Therapeutics discloses de minimis cash holdings at Silicon Valley Bank

## Summary
- Company holds low single digit millions of USD in cash and equivalents at Silicon Valley Bank.
- Disclosure made on March 10, 2023, amid SVB's collapse.
- Amount is described as de minimis, indicating limited exposure.
- Item 7.01 Regulation FD Disclosure filed with SEC as an 8-K.

## SEC filing metadata
- accession: 0001193125-23-067504
- form_type: 8-K
- ticker: VRDN
- cik: 0001590750
- company_name: Viridian Therapeutics, Inc.\DE
- filed_at: 2023-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1590750/000119312523067504/0001193125-23-067504-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1590750/000119312523067504/d354375d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-067504
- JSON: https://secwatch.observer/filing/0001193125-23-067504.json
- Plain text: https://secwatch.observer/filing/0001193125-23-067504.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.